Network pharmacology and AI: illuminating the path to precision herbal medicine in Ganoderma spp.

Abstract

Ganoderma species are promising sources of bioactive natural products with substantial pharmacological potential and have long been valued in traditional Chinese medicine (TCM) for their diverse therapeutic properties. However, their complex multi-component, multi-target nature presents significant challenges in elucidating pharmacodynamic mechanisms and optimizing clinical applications. Recent advances in network pharmacology (NP) and artificial intelligence (AI) offer innovative strategies to address these challenges. NP integrates compound-target-pathway-disease networks, while AI enhances predictive modeling, target prioritization, and the analysis of large-scale pharmacological data. Together, these approaches facilitate mechanistic interpretation, rational formulation, and personalized use of Ganoderma-derived medicines. This review highlights recent progress in applying NP and AI to identify key bioactive constituents and therapeutic pathways of Ganoderma spp., while also addressing limitations related to data quality, standardization, and clinical translation. By emphasizing the synergy between traditional TCM theory and modern computational technologies, this integrative approach advances natural medicine research and holds promise for strengthening the scientific foundation and global acceptance of Ganoderma-based therapeutics.

Keywords

Traditional Chinese Medicine / Ganoderma spp / Artificial intelligence / Fungi / Herbal medicine / Bioactive compounds / Therapeutic pathways

Funding

This work was supported by the project (No. CZ.02.01.01/00/22_008/000463). Materials and technologies for sustainable development within the Jan Amos Komensky Operational Program financed by the European Union and from the state budget of the Czech Republic.

Declaration of competing interests

These authors have no conflict of interest to declare.

References

[1] Joshi CP, Baldi A, Kumar N, et al. Harnessing network pharmacology in drug discovery: an integrated approach. Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(5):4689-4703. https://doi.org/10.1007/s00210-024-03625-3.

[2] Pei L, Bao Y, Liu S, et al. Material basis of Chinese herbal formulas explored by combining pharmacokinetics with network pharmacology. PLoS One. 2013; 8(1):e57414. https://doi.org/10.1371/journal.pone.0057414.

[3] Li S, Zhang B, Zhang N. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol. 2011; 5(Suppl 1):S10. doi: 10.1186/1752-0509-5-S1-S10.

[4] Assenov Y, Ramírez F, Schelhorn SE, et al. Computing topological parameters of biological networks. Bioinformatics. 2008; 24(2):282-284. https://doi.org/10.1093/bioinformatics/btm554.

[5] Meng W, Chao W, Kaiwei Z, et al. Bioactive compounds from Chinese herbal plants for neurological health: mechanisms, pathways, and functional food applications. Front Nutr. 2025; 12:1537363. https://doi.org/10.3389/fnut.2025.1537363.

[6] Chen Y, Tang Y, Li Y, et al. Enhancing the efficacy of active pharmaceutical ingredients in medicinal plants through nanoformulations: a promising field. Nanomaterials. 2024; 14(19):1598. https://doi.org/10.3390/nano14191598.

[7] Wang C, Ren K, Yang M, et al. How Traditional Chinese Medicine can play a role in nanomedicine? A comprehensive review of the literature. Int J Nanomed. 2025; 20:6289-315. https://doi.org/10.2147/IJN.S518610.

[8] Du HZ, Hou XY, Miao YH, et al. Traditional Chinese medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP). Chin J Nat Med. 2020; 18(3):206-210. https://doi.org/10.1016/S1875-5364.

[9] Song Z, Chen G, Chen CYC. AI empowering traditional Chinese medicine.? Chem Sci. 2024; 15(46):16844-16886. https://doi.org/10.1039/d4sc04107k.

[10] Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/. 1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. https://doi.org/10.1021/acs.jnatprod.9b01285.

[11] Sliva D. Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini Rev Med Chem. 2004; 4(8):873-879. https://doi.org/10.2174/1389557043403323.

[12] Khanal S, Thakur P, Sharma A, et al. Unlocking the therapeutic potential of bioactive compounds in Ganoderma lucidum: a new frontier in natural medicine. 3 Biotech. 2025; 15(7):21. https://doi.org/10.1007/s13205-025-04353-y.

[13] Kumar HMA, Sarkar M, Darshan K, et al. The Ganoderma:biodiversity and significance. In: Mushrooms: Biodiversity, Nutritional and Medicinal Value. Springer; 2022:255-291. https://doi.org/10.1007/978-981-16-8877-5_12.

[14] Li JF, Guo HL, Dong Y, et al. Polysaccharides from Chinese herbal medicine: a review on the hepatoprotective and molecular mechanism. Chin J Nat Med. 2024; 22(1):4-14. https://doi.org/10.1016/S1875-5364(24)60558-3.

[15] Varghese R, Dalvi YB, Lamrood PY, et al. Historical and current perspectives on the therapeutic potential of higher basidiomycetes: an overview. 3 Biotech. 2019; 9(1):1-15. https://doi.org/10.1007/s13205-019-1886-2.

[16] Pascale C, Sirbu R, Cadar E. Importance of bioactive compounds of extract in medical field. Eur J Nat Sci Med. 2022; 5(1):40-48. https://doi.org/10.26417/ejnmed.v5i1p40-48.

[17] Xiong C, Chen C, Chen ZQ, et al. Potentiation of neuritogenic activity of Ganoderma leucocontextum on rat pheochromocytoma cells. Nat Prod Res Dev. 2016; 28(7):1135-1139. https://doi.org/10.16333/j.1001-6880.2016.7.025.

[18] Li X, Xie Y, Peng J, et al. Ganoderiol F purified from Ganoderma leucocontextum retards cell cycle progression via inhibiting CDK4/CDK6. Cell Cycle. 2019; 18(21):3030-3043. doi: 10.1080/15384101.2019.1667705.

[19] Zhao ZZ, Chen HP, Li ZH, et al. Leucocontextins A-R, lanostane-type triterpenoids from Ganoderma leucocontextum. Fitoterapia. 2016; 109:91-98. https://doi.org/10.1016/j.fitote.2015.12.004.

[20] Wang K, Bao L, Xiong W, et al. Lanostane triterpenes from the Tibetan medicinal mushroom Ganoderma leucocontextum and their inhibitory effects on HMG-CoA reductase and α-glucosidase. J Nat Prod. 2015; 78(9):1977-1989. https://doi.org/10.1021/acs.jnatprod.5b00331.

[21] Peng G, Xiong C, Zeng X, et al. Exploring nutrient profiles, phytochemical composition, and the antiproliferative activity of Ganoderma lucidum and Ganoderma leucocontextum: a comprehensive comparative study. Foods. 2024; 13(5):775. https://doi.org/10.3390/foods13050775.

[22] Zhai Y, Liu L, Zhang F, et al. Network pharmacology: a crucial approach in traditional Chinese medicine research. Chin Med. 2025; 20(1):1-20. https://doi.org/10.1186/s13020-024-01056-z.

[23] Wu J, Zhang F, Li Z, et al. Integration strategy of network pharmacology in traditional Chinese medicine: a narrative review. J Tradit Chin Med. 2022; 42(3):479-484. https://doi.org/10.19852/j.cnki.jtcm.20220328.001.

[24] Xu F, Cai W, Ma T, et al. Traditional uses, phytochemistry, pharmacology, quality control, industrial application, pharmacokinetics and network pharmacology of Pogostemon cablin: a comprehensive review. Am J Chin Med. 2022; 50(3):691-721. https://doi.org/10.1142/S0192415X22500288.

[25] Li N, Gu X, Liu F, et al. Network pharmacology-based analysis of potential mechanisms of myocardial ischemia-reperfusion injury by total salvianolic acid injection. Front Pharmacol. 2023; 14:1202718. https://doi.org/10.3389/fphar.2023.1202718.

[26] Dai Y, Chen X, Yang H, et al. Evidence construction of Huangkui Capsule against chronic glomerulonephritis: a systematic review and network pharmacology. Phytomedicine. 2022; 102:154189. https://doi.org/10.1016/j.phymed.2022.154189.

[27] Zhai Y, Zhang F, Zhou J, et al. Mechanism of norcantharidin intervention in gastric cancer: analysis based on antitumor proprietary Chinese medicine database, network pharmacology, and transcriptomics. Chin Med. 2024; 19(1):1-21. https://doi.org/10.1186/s13020-024-01000-1.

[28] Qiu Y, Mao ZJ, Ruan YP, et al. Exploration of the anti-insomnia mechanism of Ganoderma via central-peripheral multi-level interaction network analysis. BMC Microbiol. 2021; 21(1):1-16. https://doi.org/10.1186/s12866-021-02361-5.

[29] Zhang H, Xu Z, Gao H, et al. Systematic analysis on the mechanism of Zhizi-Bopi Decoction against hepatitis B via network pharmacology and molecular docking. Biotechnol Lett. 2023; 45(4):463-478. https://doi.org/10.1007/s10529-023-03359-x.

[30] Agamah FE, Bayjanov JR, Niehues A, et al. Computational approaches for network-based integrative multi-omics analysis. Front Mol Biosci. 2022; 9:967205. https://doi.org/10.3389/fmolb.2022.967205.

[31] Chen Z, Zhao M, You L, et al. Developing an artificial intelligence method for screening hepatotoxic compounds in traditional Chinese medicine and western medicine combination. Chin Med. 2022; 17(1):1-7. https://doi.org/10.1186/s13020-022-00617-4.

[32] Jia S, Lai H, Bai H, et al. Harnessing the application of artificial intelligence in identification of traditional Chinese medicines. J Ethnopharmacol. 2026;355(Pt B):120704. https://doi.org/10.1186/1752-0509-5-S1-S10.

[33] Saldívar-González FI, Aldas-Bulos VD, Medina-Franco JL, et al. Natural product drug discovery in the artificial intelligence era. Chem Sci. 2022; 13(6):1526-1546. https://doi.org/10.1039/d1sc04471k.

[34] Wang J, Liu YM, Li J, et al. Artificial intelligence in Traditional Chinese Medicine: multimodal fusion and machine learning for enhanced diagnosis and treatment efficacy. Current Medical Science. 2025; 45:1013-1022. https://doi.org/10.1007/s11596-025-00103-6.

[35] Zhang H, Ni W, Li J, et al. Artificial intelligence-based traditional Chinese medicine assistive diagnostic system: validation study. JMIR Med Inform. 2020; 8(6):e17608. https://doi.org/10.2196/17608.

[36] Guo F, Tang X, Zhang W, et al. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi Granules as an example. Pharmacol Res. 2020; 160:105077. https://doi.org/10.1016/j.phrs.2020.105077.

[37] Zhou W, Yang K, Zeng J, et al. FordNet: recommending traditional Chinese medicine formula via deep neural network integrating phenotype and molecule. Pharmacol Res. 2021; 173:105752. https://doi.org/10.1016/j.phrs.2021.105752.

[38] Zhu C, Cai T, Jin Y, et al. Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes. Pharmacol Res. 2020; 159:104935. https://doi.org/10.1016/j.phrs.2020.104935.

[39] Gan X, Shu Z, Wang X, et al. Network medicine framework reveals generic herb-symptom effectiveness of traditional Chinese medicine. Sci Adv. 2023; 9(28):eadh0215. https://doi.org/10.1126/sciadv.adh0215.

[40] Zhang S, Wang W, Pi X, et al. Advances in the application of traditional Chinese medicine using artificial intelligence: a review. Am J Chin Med. 2023; 51(6):1067-1083. https://doi.org/10.1142/S0192415X23500490.

[41] Tian Z, Wang D, Sun X, et al. Current status and trends of artificial intelligence research on the four traditional Chinese medicine diagnostic methods: a scientometric study. Ann Transl Med. 2023; 11(2):145. https://doi.org/10.21037/atm-22-5905.

[42] Ma S, Liu J, Li W, et al. Machine learning in TCM with natural products and molecules: current status and future perspectives. Chin Med. 2023; 18(1):1-17. https://doi.org/10.1186/s13020-023-00741-9.

[43] Zhou E, Shen Q, Hou Y. Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review. Front Pharmacol. 2024; 15:1181183. https://doi.org/10.3389/fphar.2024.1181183.

[44] Li W, Ge X, Liu S, et al. Opportunities and challenges of traditional Chinese medicine doctors in the era of artificial intelligence. Front Med (Lausanne). 2023; 10:1336175. https://doi.org/10.3389/fmed.2023.1336175.

[45] Zhang P, Wang B, Li S. Network-based cancer precision prevention with artificial intelligence and multi-omics. Sci Bull. 2023; 68(13):1219-1222. https://doi.org/10.1016/j.scib.2023.05.021.

[46] Li S, Ding Q, Wang X. “Network target” theory and network pharmacology. In: Network Pharmacology. Springer; 2021:1-34. https://doi.org/10.1007/978-981-16-0753-0_1.

[47] Li X, Wu L, Liu W, et al. A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action. PLoS One. 2014; 9(5):e95004. https://doi.org/10.1371/journal.pone.0095004.

[48] Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang Pill as a case study. Mol Biosyst. 2014; 11(2):535-543. https://doi.org/10.1039/c3mb70507b.

[49] Zhang RZ, Yu SJ, Bai H, et al. TCM-Mesh:the database and analytical system for network pharmacology analysis for TCM preparations. Sci Rep. 2017; 7: 2821. https://doi.org/10.1038/s41598-017-03039-7.

[50] Prasad TS, Goel R, Kandasamy K, et al. Human protein reference database—2009 update. Nucleic Acids Res. 2009;37:D767-D772. doi: 10.1093/nar/gkn892.

[51] Brown KR, Jurisica I.Online predicted human interaction database. Bioinformatics. 2005; 21(9):2076-2082. https://doi.org/10.1093/bioinformatics/bth315.

[52] Gao Z, Li H, Zhang H, et al. PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics. 2008; 9:104. https://doi.org/10.1186/1471-2105-9-104.

[53] Whirl-Carrillo M, McDonagh EM, Hebert JM, et al.Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2012; 92(4):414-417. https://doi.org/10.1038/clpt.2012.96.

[54] Klimov KY. Analysis of retinoblastoma-associated genes using bioinformatic methods. Digit Diagn. 2023; 4(1):66-69. https://doi.org/10.17816/DD430347.

[55] Vastrik I, D’Eustachio P, Schmidt E, et al. Reactome: a knowledge base of biologic pathways and processes. Genome Biol. 2007; 8(3):R39. https://doi.org/10.1186/gb-2007-8-3-r39.

[56] Fazekas D, Koltai M, Türei D, et al. SignaLink 2—a signaling pathway resource with multi-layered regulatory networks. BMC Syst Biol. 2013; 7(1):7. https://doi.org/10.1186/1752-0509-7-7.

[57] Durán-Iturbide NA, Díaz-Eufracio BI, Medina-Franco JL. In silico ADME/Tox profiling of natural products: a focus on BIOFACQUIM. ACS Omega. 2020; 5(26):16076-16084. https://doi.org/10.1021/acsomega.0c01581.

[58] Li X, Ren J, Zhang W, et al. LTM-TCM: a comprehensive database for the linking of traditional Chinese medicine with modern medicine at molecular and phenotypic levels. Pharmacol Res. 2022; 178:106185. https://doi.org/10.1016/j.phrs.2022.106185.

[59] Chen X, Liu MX, Yan GY.Drug-target interaction prediction by random walk on the heterogeneous network. Mol Biosyst. 2012; 8(7):1970-1978. https://doi.org/10.1039/c2mb00002d.

[60] Vanunu O, Magger O, Ruppin E, et al. Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol. 2010; 6(1):e1000641. https://doi.org/10.1371/journal.pcbi.1000641.

[61] Zhang R, Zhu X, Bai H, et al. Network pharmacology databases for traditional Chinese medicine: review and assessment. Front Pharmacol. 2019; 10:123. https://doi.org/10.3389/fphar.2019.00123.

[62] Fan M, Jin C, Li D, et al. Multi-level advances in databases related to systems pharmacology in traditional Chinese medicine: a 60-year review. Front Pharmacol. 2023; 14:1289901. https://doi.org/10.3389/fphar.2023.1289901.

[63] Huang Y, Dong D, Zhang W, et al. DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning. Database. 2024;2024:baae051. https://doi.org/10.1093/database/baae051.

[64] Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019; 47(W1):W357-W364. https://doi.org/10.1093/nar/gkz382.

[65] Keskin O, Tuncbag N, Gursoy A. Predicting protein-protein interactions from the molecular to the proteome level. Chem Rev. 2016; 116(8):4884-4909. https://doi.org/10.1021/acs.chemrev.5b00683.

[66] Zhou T, Yao J, Liu Z. Gene ontology, enrichment analysis, and pathway analysis. In: Bioinformatics in Aquaculture.Wiley; 2017:150-168. https://doi.org/10.1002/9781118782392.ch10.

[67] Rothfels K, Milacic M, Matthews L, et al. Using the Reactome database. Curr Protoc. 2023; 3(6):e722. https://doi.org/10.1002/cpz1.722.

[68] Valdés-Tresanco MS, Valdés-Tresanco ME, Valiente PA, et al. AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4. Biol Direct. 2020; 15(1):1-12. https://doi.org/10.1186/s13062-020-00267-2.

[69] Ecker GF. In silico ADME modeling. In: Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Springer; 2024:1901-1927.https://doi.org/10.1007/978-3-031-35529-5_108.

[70] Soudy M, Anwar AM, Ahmed EA, et al. UniprotR: retrieving and visualizing protein sequence and functional information from Universal Protein Resource (UniProt knowledgebase). J Proteomics. 2020; 213:103613. https://doi.org/10.1016/j.jprot.2019.103613.

[71] Iden M, Tsaih SW, Huang YW, et al. Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes. Br J Cancer. 2021; 125(10):1408-1419. https://doi.org/10.1038/s41416-021-01545-0.

[72] Bhattarai P, Rai S, Koirala P, et al. Computational approach and its application in the nutraceutical industry. In:Bioactive Extraction and Application in Food and Nutraceutical Industries. Springer; 2024:449-468. https://doi.org/10.1007/978-1-0716-3601-5_18.

[73] Kumar G, Barman P, Konwar R, et al.Natural product databases: discovering nature’s riches. In: Natural Products in Drug Discovery. Taylor Francis. 2026:555-84. https://doi.org/10.1201/9781998511297-22.

[74] Ahmed Z, Zeeshan S, Mendhe D, et al. Human gene and disease associations for clinical-genomics and precision medicine research. Clin Transl Med. 2020; 10(2):297-318. https://doi.org/10.1002/ctm2.28.

[75] Zhu H, Zhang J, Kim MT, et al. Big data in chemical toxicity research: the use of high-throughput screening assays to identify potential toxicants. Chem Res Toxicol. 2014; 27(9):1643-1651. https://doi.org/10.1021/tx500145h.

[76] Cör Andrejč D, Knez Ž, Knez Marevci M. Antioxidant, antibacterial, antitumor, antifungal, antiviral, anti-inflammatory, and nevro-protective activity of Ganoderma lucidum: an overview. Front Pharmacol. 2022; 13:934982. https://doi.org/10.3389/fphar.2022.934982.

[77] Michalska A, Sierocka M, Drzewiecka B, et al. Antioxidant and anti-inflammatory properties of mushroom-based food additives and food fortified with them—current status and future perspectives. Antioxidants (Basel). 2025; 14:519. https://doi.org/10.3390/antiox14050519.

[78] He P, Zhang Y, Li N. The phytochemistry and pharmacology of medicinal fungi of the genus Phellinus: a review. Food Funct. 2021; 12(2):1856-1881. https://doi.org/10.1039/d0fo02342f.

[79] Agnihotri C Aarzoo, Agnihotri S, et al. Mushroom bioactives: traditional resources with nutraceutical importance. In: Traditional Resources and Tools for Modern Drug Discovery. Springer; 2024:617-639. https://doi.org/10.1007/978-981-97-4600-2_24.

[80] Gafforov Y, Rašeta M, Rapior S, et al. Macrofungi as medicinal resources in Uzbekistan: biodiversity, ethnomycology, and ethnomedicinal practices. J Fungi. 2023; 9(9):922. https://doi.org/10.3390/jof9090922.

[81] Dhar GA, Karmakar R, Mukhopadhyay S, et al. Insights into natural product-based drug discovery using a systems biology approach. In: Bioactive Ingredients for Healthcare Industry Volume 1.Springer; 2025:159-180. https://doi.org/10.1007/978-981-96-3663-1_7.

[82] Eira A, Gonçalves MBS, Fongang YSF, et al. Unlocking the potential of Ganoderma lucidum (Curtis): botanical overview, therapeutic applications, and nanotechnological advances. Pharmaceutics. 2025; 17(4):422. https://doi.org/10.3390/pharmaceutics17040422.

[83] Oh KK, Adnan M, Cho DH. A network pharmacology analysis on drug-like compounds from Ganoderma lucidum for alleviation of atherosclerosis. J Food Biochem. 2021; 45(6):e13906. https://doi.org/10.1111/jfbc.13906.

[84] Zhao RL, He YM. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57BL/ 6 mice. J Ethnopharmacol. 2018; 210:287-295. https://doi.org/10.1016/j.jep.2017.08.041.

[85] Zhong JY, Chen HB, Ye DZ, et al. Molecular mechanism of Ganoderma against gastric cancer based on network pharmacology and experimental test. Chin J Chin Mater Med. 2022; 47(1):203-214. https://doi.org/10.19540/j.cnki.cjcmm.20211115.601.

[86] Shi J, Chen J, Cheng C, et al. Systems pharmacology-based drug discovery and active mechanism of Ganoderma lucidum triterpenoids for type 2 diabetes mellitus via integrating network pharmacology and molecular docking. Curr Pharm Des. 2025; 31(4):1-13. https://doi.org/10.2174/0113816128365423250126035306.

[87] Huo J, Nie K, Yang T, et al. Network pharmacology combined with transcriptomics reveals that Ganoderma lucidum spore and Sanghuangporus vaninii compound extract exerts anti-colorectal cancer effects via CYP24A1-mediated VDR pathway and TERT-mediated Wnt signaling pathway. J Ethnopharmacol. 2025; 348:119820. https://doi.org/10.1016/j.jep.2025.119820.

[88] Luo Y, Luo X, Xue Z, et al. Exploring the anti-lung cancer mechanism of Ganoderma lucidum and its relationship with the level of immune cell infiltration based on network pharmacology and molecular docking. Oncologie. 2024; 26(4):831-843. https://doi.org/10.1515/oncologie-2024-0194.

[89] Guo S, Yang L, Zhou J, et al. Mechanistic insights into Ganoderma lucidum for diabetes treatment via network pharmacology and validation. Diabetes Metab Syndr Obes. 2025; 18:1263-1284. https://doi.org/10.2147/DMSO.S500955.

[90] Mei X, Zhang J, Chen L, et al. Systematic network pharmacology and experimental validation reveal anti-glioma mechanisms of Ganoderma lucidum via multi-target regulation. Discov Oncol. 2025; 16:1467. https://doi.org/10.1007/s12672-025-03280-x.

[91] Zhilin L, Haobo F, Juan W, et al. Investigating the therapeutic potential of Ganoderma lucidum in treating optic nerve atrophy through network pharmacology and experimental validation. Biochem Biophys Res Commun. 2025; 760:151702. https://doi.org/10.1016/j.bbrc.2025.151702.

[92] Shi M. The efficacy of Ganoderma lucidum extracts on treating endometrial cancer: a network pharmacology approach. Reprod Sci. 2024; 31(6):1881-1894. https://doi.org/10.1007/s43032-024-01500-3.

[93] Qian R, Zhang L, Xu Y, et al. Network pharmacology reveals the effect and mechanism of Ganoderma leucocontextum ethanol extract on improving inflammatory response in silicosis lungs. China Occup Med. 2024; 51(1):6-15. https://doi.org/10.20001/j.issn.2095-2619.20240202.

[94] Li Y, Wang L, Xu B, et al. Based on network pharmacology tools to investigate the molecular mechanism of Cordyceps sinensis on the treatment of diabetic nephropathy. J Diabetes Res. 2021; 2021:8891093. https://doi.org/10.1155/2021/8891093.

[95] Dong J, Cao M, Yu H, et al. Network pharmacology-based exploration of the therapeutic mechanisms of Cordyceps cicadae in renal ischemia/reperfusion. Ann Transplant. 2022; 27:e937469. https://doi.org/10.12659/AOT.937469.

[96] Xiao C, Jiao C, Huang L, et al. Network pharmacology-based elucidation of the hypoglycemic mechanism of Grifola frondosa GF 5000 polysaccharides via GCK modulation in diabetic rats. Nutrients. 2025; 17(6):964. https://doi.org/10.3390/nu17060964.

[97] Kaur J, Farooqi H, Chandra K, et al. Predicting the bioactive compounds of Lentinula edodes and elucidating its interaction with genes associated to obesity through network pharmacology and in vitro cell-based assay. Heliyon. 2024; 10(5):e27363. https://doi.org/10.1016/j.heliyon.2024.e27363.

[98] Dong Y, Qiu P, Zhu R, et al. A combined phytochemistry and network pharmacology approach to reveal the potential antitumor effective substances and mechanism of Phellinus igniarius. Front Pharmacol. 2019; 10:266. https://doi.org/10.3389/fphar.2019.00266.

[99] Zan LF, Xin JC, Guo HY, et al.Systematic characterization of active antitumor constituents from the shaggy bracket medicinal mushroom Inonotus hispidus (Agaricomycetes) by UPLC-Q-TOF/MS and network pharmacology. Int J Med Mushrooms. 2023; 25(1):47-62. https://doi.org/10.1615/IntJMedMushrooms.2022044406.

[100] Wang Z, Wang R, Na Z, et al. Network pharmacology analysis of liquid-cultured Armillaria ostoyae mycelial metabolites and their molecular mechanism of action against gastric cancer. Molecules. 2024; 29(7):1668. https://doi.org/10.3390/molecules29071668.

[101] Zhou J, Wang M, Sun T, et al. Uncovering anti-influenza mechanism of Ophiocordyceps sinensis using network pharmacology, molecular pharmacology, and metabolomics. Medicine. 2023; 102(9):E34843. https://doi.org/10.1097/MD.0000000000034843.

[102] Kuang Y, Chai Y, Su H, et al. A network pharmacology-based strategy to explore the pharmacological mechanisms of Antrodia camphorata and antcin K for treating type II diabetes mellitus. Phytomedicine. 2022; 96:153851. https://doi.org/10.1016/j.phymed.2021.153851.

[103] Xiaoying M, Zhiming H, Tao Y, et al. Elucidating the molecular mechanisms underlying anti-inflammatory effects of Morchella esculenta in the arachidonic acid metabolic pathway by network pharmacology and molecular docking. Sci Rep. 2023; 13(1):1-23. https://doi.org/10.1038/s41598-023-42658-1.

[104] Pei H, He Z, Chen W, et al. Network pharmacology and molecular docking analysis on the mechanism of Cordyceps militaris polysaccharide regulating immunity through TLR4/TNF-α pathways. J Biochem Mol Toxicol. 2023; 37(4):e23345. https://doi.org/10.1002/jbt.23345.

[105] Shreya S, Kumar DN, Mohapatra D, et al. Tracing the anti-cancer mechanism of Pleurotus ostreatus by the integrative approach of network pharmacology and experimental studies. Appl Biochem Biotechnol. 2023; 195(1):152-171. https://doi.org/10.1007/s12010-022-04111-3.

[106] Jiang S, Bao H. Exploring the mechanism of esculetin extracted from Chroogomphus rutilus in treating liver cancer based on network pharmacology, molecular docking, and in vivo experimental validation. J Ethnopharmacol. 2025; 348:119837. https://doi.org/10.1016/j.jep.2025.119837.

[107] Li S, Zhang B, Jiang D, et al. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics. 2010; 11(Suppl 11):S6. doi: 10.1186/1471-2105-11-S11-S6.

[108] Morris GM, Ruth H, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(15):2785-2791. https://doi.org/10.1002/jcc.21256.

[109] Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. https://doi.org/10.1038/nprot.2008.211.

[110] Ye H, Ye L, Kang H, et al. HIT: linking herbal active ingredients to targets. Nucleic Acids Res. 2011;39:D1055-D1059. https://doi.org/10.1093/nar/gkq1165.

[111] Chen CYC. TCM Database@Taiwan: the world’s largest traditional Chinese medicine database for drug screening in silico. PLoS One. 2011; 6(1):e15939. https://doi.org/10.1371/journal.pone.0015939.

[112] Zhao R, Chen Q, He YM, et al. The effect of Ganoderma lucidum extract on immunological function and identification of its anti-tumor immunostimulatory activity based on the biological network. Sci Rep. 2018; 8:1-14. https://doi.org/10.1038/s41598-018-30881-0.

[113] Liu C, Cheng Y, Guo D, et al. A new concept on quality marker for quality assessment and process control of Chinese medicines. Chin Herb Med. 2017; 9(1):3-13. https://doi.org/10.1016/S1674-6384(17)60070-4.

[114] Liu Z, Guo F, Wang Y, et al. BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine. Sci Rep. 2016; 6:21146. https://doi.org/10.1038/srep21146.

[115] Li Y, Zhang Y, Wang Y, et al. A strategy for the discovery and validation of toxicity quality marker of Chinese medicine based on network toxicology. Phytomedicine. 2019; 54:365-370. https://doi.org/10.1016/j.phymed.2018.10.003.

[116] Wang M, Lamers RJAN, Korthout HAAJ, et al. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res. 2005; 19(3):173-182. https://doi.org/10.1002/ptr.1624.

[117] Wang H, Chen Y, Wang L, et al. Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Front Pharmacol. 2023; 14:1265178. https://doi.org/10.3389/fphar.2023.1265178.

[118] Wang M, Yin F, Kong L, et al. Chinmedomics: a potent tool for the evaluation of traditional Chinese medicine efficacy and identification of its active components. Chin Med. 2024; 19:47. https://doi.org/10.1186/s13020-024-00917-x.

[119] Ahmad A, Imran M, Ahsan H. Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases. Pharmaceutics. 2023; 15(6):1630. https://doi.org/10.3390/pharmaceutics15061630.

[120] Wang Y, Cui T, Li Y, et al. Prediction of quality markers of traditional Chinese medicines based on network pharmacology. Chin Herb Med. 2019; 11(4):349-356. https://doi.org/10.1016/j.chmed.2019.08.004.

[121] Kapoor G, Prakash S, Jaiswal V, et al. Chronic inflammation and cancer: key pathways and targeted therapies. Cancer Invest. 2025; 43:1. https://doi.org/10.1080/07357907.2024.2437614.

[122] Zhang XT, Ji CL, Fu YJ, et al. Screening of active components of Ganoderma lucidum and decipher its molecular mechanism to improve learning and memory disorders. Biosci Rep. 2024; 44(5):1-15. https://doi.org/10.1042/BSR20240127.

[123] Kumar A, Behl T, Jamwal S, et al. Exploring the molecular approach of COX and LOX in Alzheimer’s and Parkinson’s disorder. Mol Biol Rep. 2020; 47:9895-9912. https://doi.org/10.1007/s11033-020-06033-x.

[124] Cheng KC, Huang HC, Chen JH et al. Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction. BMC Genomics. 2007; 8:411. https://doi.org/10.1186/1471-2164-8-411.

[125] Zhao X, Xiu J, Yang H, et al. Network pharmacology and bioinformatics study of six medicinal food homologous plants against colorectal cancer. Int J Mol Sci. 2025; 26(3):1-18. https://doi.org/10.3390/ijms26030930.

[126] Swallah MS, Bondzie-Quaye P, Wu Y, et al. Therapeutic potential and nutritional significance of Ganoderma lucidum-a comprehensive review from 2010 to 2022. Food Funct. 2023; 14:1812-38. https://doi.org/10.1039/d2fo01683d.

[127] Wu M, Zhang Y. Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes. Front Endocrinol. 2022; 13:1030278. https://doi.org/10.3389/fendo.2022.1030278.

[128] Xu P, Lin B, Deng X, et al. Anti-osteoporosis effects of Anemarrhenae Rhizoma/Phellodendri Chinensis Cortex herb pair and its major active components in diabetic rats and zebrafish. J Ethnopharmacol. 2022; 293:115269. https://doi.org/10.1016/j.jep.2022.115269.

[129] Mukherjee A, Abraham S, Singh A, et al. From data to cure: a comprehensive exploration of multi-omics data analysis for targeted therapies. Mol Biotechnol. 2024; 67(4):1269-1289. https://doi.org/10.1007/s12033-024-01133-6.

[130] Cui G, Li M, Guo W, et al. AI-driven network pharmacology: multi-scale mechanisms of traditional Chinese medicine from molecular to patient analysis. Comput Struct Biotechnol J. 2025; 27:5087. https://doi.org/10.1016/j.csbj.2025.11.016.

[131] Qian R, Xu Y, Zhang L, et al. Ganoderma leucocontextum ethanol extract alleviates silica-induced pulmonary injury via TGF-β1/RUNX3/SMADs pathway. J Ethnopharmacol. 2026; 355:120757. https://doi.org/10.1016/j.jep.2025.120757.

[132] Zhong L, Yan P, Lam WC, et al. Coriolus versicolor and Ganoderma lucidum related natural products as an adjunct therapy for cancers: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2019; 10:1222. https://doi.org/10.3389/fphar.2019.01222.

[133] Zhao H, Shao Y, Mao C, et al. Research progress on antitumor effects of active proteins, polysaccharides, and triterpenoids in. Ganoderma lucidum. J Biotech Res. 2023; 14:171-184.

[134] Chaitanya MVNL, Pereira G, Ali HS. Alternative remedies and natural products for cancer therapy: an integrative approach. In: Alternative Remedies and Natural Products for Cancer Therapy: an Integrative Approach. Springer; 2023:1-309. https://doi.org/10.1007/978-981-19-9109-0.

[135] Jakopovic B, Oršolić N, Jakopovich I. Proteomic research on the antitumor properties of medicinal mushrooms. Molecules. 2021; 26(21):6708. https://doi.org/10.3390/molecules26216708.

[136] Sevindik M, Eraslan EC, Krupodorova T, et al. The role of medicinal mushrooms in cancer treatment: bioactive compounds and therapeutic potential. Int J Med Mushrooms. 2025; 27(1):1-25. https://doi.org/10.1615/IntJMedMushrooms.2024051758.

[137] Gao X, Homayoonfal M. Exploring the anti-cancer potential of Ganoderma lucidum polysaccharides (GLPs) and their versatile role in enhancing drug delivery systems: a multifaceted approach to combat cancer. Cancer Cell Int. 2023; 23(1):1-29. https://doi.org/10.1186/s12935-023-03146-8.

[138] Thongsawang S. Effects of Cordyceps sinensis supplementation combined with repeated sprint training in hypoxia on markers of oxidative stress and physical performance in female soccer. Chulalongkorn University Theses and Dissertations (Chula ETD). 2023.

[139] Liu W, Gao Y, Zhou Y, et al. Mechanism of Cordyceps sinensis and its extracts in the treatment of diabetic kidney disease: a review. Front Pharmacol. 2022; 13:881835. https://doi.org/10.3389/fphar.2022.881835.

[140] Varnosfaderani SMN, Ebrahimzadeh F, Oryani MA, et al. Potential promising anticancer applications of β-glucans: a review. Biosci Rep. 2024; 44(1):BSR20231686. https://doi.org/10.1042/BSR20231686.

[141] Dai X. The mechanism by which Lentinula edodes modulates cytokine production of innate immune cells. West Virginia University. 2015.

[142] Masuda Y, Nawa D, Nakayama Y, et al. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity. J Leukoc Biol. 2015; 98(5):1015-1025. https://doi.org/10.1189/jlb.1A0814-415RR.

[143] Garcia J, Rodrigues F, Saavedra MJ, et al. Bioactive polysaccharides from medicinal mushrooms: a review on their isolation, structural characteristics and antitumor activity. Food Biosci. 2022; 49:101955. https://doi.org/10.1016/j.fbio.2022.101955.

[144] Roda E, Priori EC, Ratto D, et al. Neuroprotective metabolites of Hericium erinaceus promote neuro-healthy aging. Int J Mol Sci. 2021; 22(12):6379. https://doi.org/10.3390/ijms22126379.

[145] Szućko-Kociuba I, Trzeciak-Ryczek A, Kupnicka P, et al. Neurotrophic and neuroprotective effects of. Hericium erinaceus. Int J Mol Sci. 2023; 24(21):15960. https://doi.org/10.3390/ijms242115960.

[146] Yen YT, Park JH, Kang SH, et al. Clinical benefits of golden-Antrodia camphorata containing antroquinonol in liver protection and liver fat reduction after alcoholic hepatitis. Front Pharmacol. 2022; 13:757494. https://doi.org/10.3389/fphar.2022.757494.

[147] Li ZW, Kuang Y, Tang SN, et al. Hepatoprotective activities of Antrodia camphorata and its triterpenoid compounds against CCl4-induced liver injury in vivo. J Ethnopharmacol. 2017; 206:31-39. https://doi.org/10.1016/j.jep.2017.04.015.

[148] Wang Y, Gu J, Wu J, et al. Natural products and health care functions of. Inonotus obliquus. Curr Issues Mol Biol. 2025; 47(4):269. https://doi.org/10.3390/cimb47040269.

[149] Ingo C. A comparative study between the medicinal mushrooms Inonotus obliquus and Ganoderma lucidum—an analysis between polysaccharides, triterpenes and their functions. Alato University. 2013.

[150] Li Y, Liu X, Zhou J, et al. Artificial intelligence in traditional Chinese medicine: advances in multi-metabolite multi-target interaction modeling. Front Pharmacol. 2025; 16:1541509. https://doi.org/10.3389/fphar.2025.1541509.

[151] Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014; 6(1):1-6. https://doi.org/10.1186/1758-2946-6-13.

[152] Xue R, Fang Z, Zhang M, et al. TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res. 2013; 41(D1):D1089-D1095. https://doi.org/10.1093/nar/gks1100.

[153] Wang Y, Liu M, Jafari M, Tang J. A critical assessment of Traditional Chinese Medicine databases as a source for drug discovery. Front Pharmacol. 2024; 15:1303693. https://doi.org/10.3389/fphar.2024.1303693.

[154] Li XL, Zhang JQ, Shen XJ, et al. Overview and limitations of database in global traditional medicines: A narrative review. Acta Pharmacol Sin. 2025; 46:235-63. https://doi.org/10.1038/s41401-024-01353-1.

[155] Akhtar M, Nehal N, Gull A, et al. Explicating the transformative role of artificial intelligence in designing targeted nanomedicine. Expert Opin Drug Deliv. 2025; 22(10):971-991. https://doi.org/10.1080/17425247.2025.2502022.

[156] Vitorino R. Transforming clinical research: the power of high-throughput omics integration. Proteomes. 2024; 12(3):25. https://doi.org/10.3390/proteomes12030025.

[157] Cho MH, Jin H, Ha J, et al. An integrated systems pharmacology approach combining bioinformatics, untargeted metabolomics and molecular dynamics to unveil the anti-aging mechanisms of Tephroseris flammea. Biomolecules. 2025; 15(12):1740. https://doi.org/10.3390/biom15121740.

[158] Yang L, Wang H, Zhu Z, et al. Network pharmacology-driven sustainability: AI and multi-omics synergy for drug discovery in traditional Chinese medicine. Pharmaceuticals. 2025; 18(7):1074. https://doi.org/10.3390/ph18071074.

[159] Moreira-Filho JT, Silva AC, Dantas RF, et al. Schistosomiasis drug discovery in the era of automation and artificial intelligence. Front Immunol. 2021; 12:642383. https://doi.org/10.3389/fimmu.2021.642383.

[160] Chaudhari R, Tan Z, Huang B, et al. Computational polypharmacology: a new paradigm for drug discovery. Expert Opin Drug Discov. 2017; 12(3):279-291. https://doi.org/10.1080/17460441.2017.1280024.

[161] Creanza TM, Lamanna G, Delre P, et al. DeLA-Drug: a deep learning algorithm for automated design of druglike analogues. J Chem Inf Model. 2022; 62(6):1411-1424. https://doi.org/10.1021/acs.jcim.2c00205.

[162] Niazi SK. Artificial intelligence in small-molecule drug discovery: a critical review of methods, applications, and real-world outcomes. Pharmaceuticals. 2025; 18(9):1271. https://doi.org/10.3390/ph18091271.

[163] Russell R, Aloy P, et al. Targeting and tinkering with interaction networks. Nat Chem Biol. 2008; 4:666. https://doi.org/10.1038/nchembio.119.

[164] Xu J, Bai L, Yang M, et al. Advances in the application of artificial intelligence in mass spectrometry-based analysis of traditional Chinese medicine: compound identification and metabolic pathway elucidation. Anal Bioanal Chem. 2025; 2025:1-16. https://doi.org/10.1007/s00216-025-06260-w.

[165] Fontanella F, D’Alessandro T, Nardone E, et al. Artificial intelligence for natural products drug discovery in neurodegeneration therapies: a review. Biomolecules. 2026; 16:129. https://doi.org/10.3390/biom16010129.

[166] Patil VS, Deshpande SH, Harish DR, et al. Gene set enrichment analysis, network pharmacology and in silico docking approach to understand the molecular mechanism of traditional medicines for the treatment of diabetes mellitus. J Proteins Proteomics. 2020; 11(4):297-310. https://doi.org/10.1007/s42485-020-00049-4.

[167] Zhang R, Wen H, Lin Z, et al. Artificial intelligence-driven drug toxicity prediction: advances, challenges, and future directions. Toxics. 2025; 13(7):525. https://doi.org/10.3390/toxics13070525.

[168] Xia Q, Herath Mudiyanselage SHB, Lafond S, et al. In Silico modeling of nanoparticles transport across the blood-brain barrier: a systematic review. Comput Struct Biotechnol J. 2026; 35(3):0020. https://doi.org/10.34133/csbj.0020.

[169] Huang YX, Zhao J, Song QH, et al. Virtual screening and experimental validation of novel histone deacetylase inhibitors. BMC Pharmacol Toxicol. 2016; 17(1):1-14. https://doi.org/10.1186/s40360-016-0075-8.

[170] Zhou S, Zhang H, Li J, et al. Potential anti-liver cancer targets and mechanisms of kaempferitrin based on network pharmacology, molecular docking and experimental verification. Comput Biol Med. 2024; 178:108693. https://doi.org/10.1016/j.compbiomed.2024.108693.

[171] Noor F, Qamar MTU, Ashfaq UA, et al. Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals. 2022; 15(5):572. https://doi.org/10.3390/ph15050572.

[172] Yang X, Huang K, Yang D, et al. Biomedical big data technologies, applications, and challenges for precision medicine: a review. Glob Chall. 2024; 8(3):2300163. https://doi.org/10.1002/gch2.202300163.

[173] Brugere I, Gallagher B, Berger-Wolf TY.Network structure inference, a survey. ACM Comput Surv. 2018; 51(2):1-37. https://doi.org/10.1145/3154524.

[174] Wang B, Zhang T, Liu Q, et al. Elucidating the role of artificial intelligence in drug development from the perspective of drug-target interactions. J Pharm Anal. 2025; 15(1):101144. https://doi.org/10.1016/j.jpha.2024.101144.

[175] Ke Z, Liu M, Liu J, et al. The application of artificial intelligence in the research and development of traditional Chinese medicine. Int J Drug Discov Pharmacol. 2024; 3(1):100001. https://doi.org/10.53941/ijddp.2024.100001.

[176] Hassija V, Chamola V, Mahapatra A, et al. Interpreting black-box models: a review on explainable artificial intelligence. Cogn Comput. 2024; 16(1):45-74. https://doi.org/10.1007/s12559-023-10179-8.

[177] Wang A, Luo Q, Tan X, et al. Development and application of artificial intelligence in traditional Chinese medicine research and development. Chin Med. 2026; 21:17. https://doi.org/10.1186/s13020-025-01288-7.

[178] Eicher T, Kinnebrew G, Patt A, et al. Metabolomics and multi-omics integration: a survey of computational methods and resources. Metabolites. 2020; 10(5):202. https://doi.org/10.3390/metabo10050202.

[179] Taha HA, Zeilani RS, Haddad RH, et al. Artificial intelligence and machine learning techniques for predicting neuropathic pain in patients with cancer: a systematic review. Digit Health. 2025; 11:1-15. https://doi.org/10.1177/20552076251358315.

[180] Ou H, Ye X, Huang H, et al. Constructing a screening model to obtain the functional herbs for the treatment of active ulcerative colitis based on herb-compound-target network and immuno-infiltration analysis. Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(5):4693-4711. https://doi.org/10.1007/s00210-023-02900-z.

[181] Venkataraman M, Gopi C, Rao JK, et al. Leveraging machine learning models in evaluating ADMET properties for drug discovery and development. ADMET DMPK. 2025; 13(1):2772. https://doi.org/10.5599/admet.2772.

[182] Khan SR, Al Rijjal D, Piro A, et al. Integration of AI and traditional medicine in drug discovery. Drug Discov Today. 2021; 26(5):982-992. https://doi.org/10.1016/j.drudis.2021.02.019.

[183] Gupta U, Pranav A, Kohli A, et al. The contribution of artificial intelligence to drug discovery: current progress and prospects for the future. In:. Microorganisms for Sustainability. Springer; 2024:1-23. https://doi.org/10.1007/978-981-99-9621-6_1.

[184] Zheng X, Cai Z. Privacy-preserved data sharing towards multiple parties in industrial IoTs. IEEE J Sel Areas Commun. 2020; 38(5):968-979. https://doi.org/10.1109/JSAC.2020.2980802.

[185] Lim J, Li J, Zhou M, et al. Machine learning research trends in traditional Chinese medicine: a bibliometric review. Int J Gen Med. 2024; 17:5397-5414. https://doi.org/10.2147/IJGM.S500001.

[186] Yu Y, Yao C, Guo DA. Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry. Acta Pharm Sin B. 2021; 11(4):1469-1492. https://doi.org/10.1016/j.apsb.2021.03.002.

[187] Huang R, Ma S, Dai S, et al. Application of data fusion in traditional Chinese medicine: a review. Sensors. 2024; 24(1):106. https://doi.org/10.3390/s24010106.

[188] Khanal S, Sharma A, Pillai M, et al. Artificial intelligence-driven innovation in Ganoderma spp.: potentialities of their bioactive compounds as functional foods. Sustain Food Technol. 2025; 3(4):759-775. https://doi.org/10.1039/d4fb00357h.

[189] Grienke U, Kaserer T, Pfluger F, et al. Accessing biological actions of Ganoderma secondary metabolites by in silico profiling. Phytochemistry. 2015; 114:114-124. https://doi.org/10.1016/j.phytochem.2014.10.013.

[190] Vassaux A, Meunier L, Vandenbol M, et al. Nonribosomal peptides in fungal cell factories: from genome mining to optimized heterologous production. Biotechnol Adv. 2019; 37(6):107449. https://doi.org/10.1016/j.biotechadv.2019.107449.

[191] Cao R, Wu X, Wang Q, et al. Characterization of γ-Cadinene enzymes in Ganoderma lucidum and Ganoderma sinensis from Basidiomycetes provides insight into the identification of terpenoid synthases. ACS Omega. 2022; 7(8):7229-7239. https://doi.org/10.1021/acsomega.1c06792.

[192] Tran PN, Yen MR, Chiang CY, et al. Detecting and prioritizing biosynthetic gene clusters for bioactive compounds in bacteria and fungi. Appl Microbiol Biotechnol. 2019; 103:3277-3287. https://doi.org/10.1007/s00253-019-09708-z.

[193] Yang JS, Tsai SC, Hsu YM, et al. Integrating natural product research laboratory with artificial intelligence: advancements and breakthroughs in traditional medicine. Biomedicine (Taipei). 2024; 14(1):1. https://doi.org/10.3772/tw.2024.001.

[194] Latif R, Nawaz T. Medicinal plants and human health: a comprehensive review of bioactive compounds, therapeutic effects, and applications. Phytochem Rev. 2026; 25:2299. https://doi.org/10.1007/s11101-025-10194-7.

[195] Tripathi MK, Nath A, Singh TP, et al. Evolving scenario of big data and artificial intelligence (AI) in drug discovery. Mol Diversity. 2021; 25(3):1439-1460. https://doi.org/10.1007/s11030-021-10256-w.

[196] Zuo R, Xiong Y, Wang J, et al. Deep learning and its application in geochemical mapping. Earth Sci Rev. 2019; 192:1-14. https://doi.org/10.1016/j.earscirev.2019.03.003.

[197] Spanakis M, Tzamali E, Tzedakis G, et al. Artificial intelligence models and tools for the assessment of drug-herb interactions. Pharmaceuticals. 2025; 18(3):282. https://doi.org/10.3390/ph18030282.

[198] Zhou J, Cui G, Hu S, et al. Graph neural networks: a review of methods and applications. AI Open. 2020; 1:57-81. https://doi.org/10.1016/j.aiopen.2021.01.001.

[199] Sanodiya BS, Thakur GS, Baghel RK, et al. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 2009; 10(5):717-742. https://doi.org/10.2174/138920109789978757.

[200] Boh B, Berovic M, Zhang J, et al. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev. 2007; 13:265-301. https://doi.org/10.1016/S1387-2656(07)13010-6.

[201] alappaththi MCA, Patabendige NM, Premarathne BM, et al. A review of Ganoderma triterpenoids and their bioactivities. Biomolecules. 2023; 13(1):24. https://doi.org/10.3390/biom13010024.

[202] Gangwal A, Lavecchia A. Artificial intelligence in natural product drug discovery: current applications and future perspectives. J Med Chem. 2025; 68(5):3948-3969. https://doi.org/10.1021/acs.jmedchem.4c01257.

[203] Gurung M, Shrestha S, Professor A. Machine learning in modern drug discovery: applications, advances, and future horizons. KEC J Sci Eng. 2025; 9:116-126.

[204] Chen M, Ji G, Fu H, et al. A survey on identification and quantification of alternative polyadenylation sites from RNA-seq data. Brief Bioinform. 2020; 21(4):1261-1276. https://doi.org/10.1093/bib/bbz068.

[205] Li X, Zhang W. Expression of PD-L1 in EBV-associated malignancies. Int Immunopharmacol. 2021; 95:107553. https://doi.org/10.1016/j.intimp.2021.107553.

[206] Cheng M, Pan H, Zhao X, et al. Integrative network pharmacology and molecular docking elucidate the multi-target mechanisms of the artist’s conk medicinal mushroom Ganoderma applanatum (Agaricomycetes) triterpenoids against hepatocellular carcinoma. Int J Med Mushrooms. 2026; 28(4):71. https://doi.org/10.1615/INTJMEDMUSHROOMS.2025062402.

[207] Kaliaperumal K, Salendra L, Liu Y, et al. Isolation of anticancer bioactive secondary metabolites from the sponge-derived endophytic fungi Penicillium sp and in-silico computational docking approach. Front Microbiol. 2023; 14:1216928. https://doi.org/10.3389/fmicb.2023.1216928.

[208] Ahmed T, Juhász A, Bose U, et al. Research trends in production, separation, and identification of bioactive peptides from fungi: a critical review. J Funct Foods. 2024; 119:106343. https://doi.org/10.1016/j.jff.2024.106343.

[209] Dong X, Gao X, Wang R, et al. Evaluation of polysaccharide content in shiitake culinary-medicinal mushroom, Lentinula edodes (Agaricomycetes), via near-infrared spectroscopy integrated with deep learning. Int J Med Mushrooms. 2023; 25(1):13-28. https://doi.org/10.1615/IntJMedMushrooms.2022044622.

[210] Wang L, Li J, Li T, et al. Method superior to traditional spectral identification: FT-NIR two-dimensional correlation spectroscopy combined with deep learning to identify the shelf life of fresh Phlebopus portentosus. ACS Omega. 2021; 6(31):19665-19674. https://doi.org/10.1021/acsomega.1c02317.

[211] Li J, Long Q, Ding H, et al. Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine. Adv Sci. 2024; 11(16):e2308677. https://doi.org/10.1002/advs.202308677.

[212] Adipo M, Mudalungu CM, Santos CBR, et al. Insect-derived compounds as novel source for drug discovery: a systematic review and critical in silico analysis. Chem Biodivers. 2025; 23:e02495. https://doi.org/10.1002/cbdv.202502495.

[213] Xu Q, Guo Q, Wang CX, et al. Network differentiation: a computational method of pathogenesis diagnosis in traditional Chinese medicine based on systems science. Artif Intell Med. 2021; 118:102134. https://doi.org/10.1016/j.artmed.2021.102134.

[214] Hou GL, Dong BQ, Yu BX, et al. Artificial intelligence in acupuncture: bridging traditional knowledge and precision integrative medicine. Front Med. 2025; 12:1633416. https://doi.org/10.3389/fmed.2025.1633416.

[215] Zhao Z, Ren X, Song K, et al. PreGenerator: TCM prescription recommendation model based on retrieval and generation method. IEEE Access. 2023; 11:103679-103692. https://doi.org/10.1109/ACCESS.2023.3316219.

[216] Wang X, Wang ZY, Zheng JH, et al. TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med. 2021; 19(1):1-11. https://doi.org/10.1016/S1875-5364(21)60001-8.